Skip to main content
Premium Trial:

Request an Annual Quote

Fitch Affirms BBB+ Ratings for Agilent

NEW YORK (GenomeWeb News) – Fitch Ratings late on Tuesday affirmed several ratings of BBB+ for Agilent Technologies.

The BBB+ ratings, which translate to good credit quality, were affirmed for Agilent's Issuer Default Rating, senior unsecured revolving credit facility, and senior unsecured notes. Fitch's actions affect about $2.6 billion of debt, including an undrawn $400 million revolving credit facility that expires in 2016, Fitch said.

It rated Agilent's outlook Stable.

Fitch noted Agilent's strengthened operating profile and continued diversification of its revenue mix, saying that though the Electronics Measurement Group still makes up about half of Agilent's total revenues and "well over half" of its operating income, faster and stable organic growth in markets served by the Life Sciences Group and Chemical Analysis Group "should tip this balance over the intermediate term."

It added that acquisitions are more likely in the Life Sciences and Chemical Analysis businesses, which would accelerate the portfolio shift, and noted the $1.5 billion Varian acquisition completed about two years ago, which added about $700 million in annual revenues to Chemical Analysis Group, and a little less than that to Life Sciences.

"Nonetheless, future acquisitions likely will be smaller in size and focused on technologies that can be leveraged by Agilent's global footprint," Fitch said in a statement.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.